Results 291 to 300 of about 170,636 (309)

The role of PFA-100R testing in the investigation and management of haemostatic defects in children and adults

British Journal of Haematology, 2005
Paul Harrison
exaly  

The PFA‐100® does not predict delta‐granule platelet storage pool deficiencies

Haemophilia, 2012
Bryce A Kérlin
exaly  

Electrochemical reduction of PFAS

Nature Chemistry
openaire   +2 more sources

MEM-PFA

Cold Spring Harbor Protocols, 2009
openaire   +1 more source

PFAS Isomers

2018
Yun Xing, Gabriel Cantu, David M. Kempisty   +2 more
openaire   +1 more source

PFAS, n.

2023
openaire   +1 more source

NEMESIS-PFA

JACC: Clinical Electrophysiology
Dhanunjaya Lakkireddy, Aashish Katapadi, Jalaj Garg, Eli Herink, Michael Klotz, Jagruth Ganta, Aanya Kabra, Rajesh Kabra, Naga Venkata Pothineni, Douglas Darden, Rangarao Tummala, Scott Koerber, Rakesh Gopinathannair, Sudharani Bommana, Donita Atkins, Rahul Chaudhary, Mackenzie Mbai, Venkat Tholakanahalli, Sanghamitra Mohanty, Luigi DiBiase, Andrea Natale   +20 more
openaire   +1 more source

PFA-100

2019
openaire   +1 more source

The PFA-100

The Journal of Cardiovascular Nursing, 2005
openaire   +1 more source

PFAS elimination and PFAS effects on COVID-19 vaccine response

Background and aims: Per- and polyfluoroalkyl substances (PFAS) are persistent compounds, some of which have long serum half-lives in humans. Yet, details about how PFAS are eliminated from the human body are limited. PFAS exposure has been associated with lower vaccine responses in children, but it is unclear whether this also occurs in adults ...
openaire   +1 more source